{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:18:07Z","timestamp":1791728287751,"version":"4.3.4"},"reference-count":56,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/ijmm.2016.2475","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T08:33:29Z","timestamp":1454056409000},"page":"743-754","source":"Crossref","is-referenced-by-count":18,"title":["Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity"],"prefix":"10.3892","volume":"37","author":[{"given":"CHIN-CHANG","family":"CHEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TZUNG-YAN","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHING-FAI","family":"KWOK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUNG-PEI","family":"HSU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KUANG-CHUNG","family":"SHIH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YAN-JIE","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LOW-TONE","family":"HO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"key20180107234242_b1-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"d3897","DOI":"10.1136\/bmj.d3897","article-title":"How big a problem is non-alcoholic fatty liver disease?","volume":"343","author":"Anstee","year":"2011","journal-title":"BMJ"},{"key":"key20180107234242_b2-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","article-title":"Lipotoxicity in the liver","volume":"5","author":"Z\u00e1mb\u00f3","year":"2013","journal-title":"World J Hepatol"},{"key":"key20180107234242_b3-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00394-012-0356-y","article-title":"Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose","volume":"52","author":"Crescenzo","year":"2013","journal-title":"Eur J Nutr"},{"key":"key20180107234242_b4-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"key20180107234242_b5-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/egh.11.11","article-title":"Mitochondrial dysfunction in nonalcoholic steatohepatitis","volume":"5","author":"Serviddio","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key20180107234242_b6-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.freeradbiomed.2007.12.029","article-title":"Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases","volume":"44","author":"Mantena","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"key20180107234242_b7-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/BJ20080868","article-title":"High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo","volume":"417","author":"Mantena","year":"2009","journal-title":"Biochem J"},{"key":"key20180107234242_b8-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J Hepatol"},{"key":"key20180107234242_b9-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/ars.2009.2634","article-title":"Redox control of liver function in health and disease","volume":"12","author":"Mar\u00ed","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"key20180107234242_b10-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","article-title":"NASH: a mitochondrial disease","volume":"42","author":"Pessayre","year":"2005","journal-title":"J Hepatol"},{"key":"key20180107234242_b11-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ncb2550","article-title":"FOXOphagy path to inducing stress resistance and cell survival","volume":"14","author":"Sandri","year":"2012","journal-title":"Nat Cell Biol"},{"key":"key20180107234242_b12-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI200112876","article-title":"The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression","volume":"108","author":"Nakae","year":"2001","journal-title":"J Clin Invest"},{"key":"key20180107234242_b13-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/db05-0705","article-title":"Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action","volume":"55","author":"Samuel","year":"2006","journal-title":"Diabetes"},{"key":"key20180107234242_b14-ijmm-37-03-0743","first-page":"2464","article-title":"Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism","volume":"116","author":"Matsumoto","year":"2006","journal-title":"J Clin Invest"},{"key":"key20180107234242_b15-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2337\/db07-0698","article-title":"Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure","volume":"57","author":"Nakae","year":"2008","journal-title":"Diabetes"},{"key":"key20180107234242_b16-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2337\/db08-1001","article-title":"FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue","volume":"58","author":"Kim","year":"2009","journal-title":"Diabetes"},{"key":"key20180107234242_b17-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/dmr.5610050804","article-title":"Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes","volume":"5","author":"Caro","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"key20180107234242_b18-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/meta.2001.19422","article-title":"Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus","volume":"50","author":"Wajngot","year":"2001","journal-title":"Metabolism"},{"key":"key20180107234242_b19-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"E718","DOI":"10.1152\/ajpendo.00156.2003","article-title":"Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice","volume":"285","author":"Altomonte","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key20180107234242_b20-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"26861","DOI":"10.1074\/jbc.M110.134023","article-title":"Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia","volume":"285","author":"Haeusler","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180107234242_b21-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/nm.2049","article-title":"Foxo1 integrates insulin signaling with mitochondrial function in the liver","volume":"15","author":"Cheng","year":"2009","journal-title":"Nat Med"},{"key":"key20180107234242_b22-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"key20180107234242_b23-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180107234242_b24-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"J Clin Invest"},{"key":"key20180107234242_b25-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.26606","article-title":"Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides","volume":"59","author":"Cinar","year":"2014","journal-title":"Hepatology"},{"key":"key20180107234242_b26-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"38041","DOI":"10.1074\/jbc.M112.377978","article-title":"Activation of cannabinoid receptor type 1 (Cb1r) disrupts hepatic insulin receptor signaling via cyclic AMP-response element-binding protein H (Crebh)-mediated induction of Lipin1 gene","volume":"287","author":"Chanda","year":"2012","journal-title":"J Biol Chem"},{"key":"key20180107234242_b27-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2012.01.032","article-title":"Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice","volume":"142","author":"Liu","year":"2012","journal-title":"Gastroenterology"},{"key":"key20180107234242_b28-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J Clin Invest"},{"key":"key20180107234242_b29-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance","volume":"16","author":"Tam","year":"2012","journal-title":"Cell Metab"},{"key":"key20180107234242_b30-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.2337\/db09-1881","article-title":"Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: The role of eNOS, p38 MAPK, and AMPK pathways","volume":"59","author":"Tedesco","year":"2010","journal-title":"Diabetes"},{"key":"key20180107234242_b31-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"21327","DOI":"10.1074\/jbc.M701759200","article-title":"Mitochondrial reactive oxygen species signal hepatocyte steatosis by regulating the phosphatidylinositol 3-kinase cell survival pathway","volume":"282","author":"Kohli","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107234242_b32-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/db07-1623","article-title":"Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes","volume":"57","author":"Tedesco","year":"2008","journal-title":"Diabetes"},{"key":"key20180107234242_b33-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bbrc.2015.03.155","article-title":"Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model","volume":"15","author":"Chen","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107234242_b34-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12038-010-0052-0","article-title":"Hormonal regulation of gluconeogenic gene transcription in the liver","volume":"35","author":"Yabaluri","year":"2010","journal-title":"J Biosci"},{"key":"key20180107234242_b35-ijmm-37-03-0743","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2410","article-title":"Hepatic manifestations of metabolic syndrome","author":"Medina-Santill\u00e1n","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"key20180107234242_b36-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jnutbio.2012.03.004","article-title":"The role of dietary fatty acids in the pathology of metabolic syndrome","volume":"23","author":"Lottenberg","year":"2012","journal-title":"J Nutr Biochem"},{"key":"key20180107234242_b37-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"Review: The role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107234242_b38-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mce.2010.01.039","article-title":"Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes","volume":"320","author":"Gao","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"key20180107234242_b39-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"27971","DOI":"10.1074\/jbc.M111.224352","article-title":"Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes","volume":"286","author":"Chanda","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107234242_b40-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"e26415","DOI":"10.1371\/journal.pone.0026415","article-title":"Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes","volume":"6","author":"Ruby","year":"2011","journal-title":"PLoS One"},{"key":"key20180107234242_b41-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.metabol.2013.06.011","article-title":"Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats","volume":"62","author":"Merroun","year":"2013","journal-title":"Metabolism"},{"key":"key20180107234242_b42-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.24733","article-title":"Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: Evidence from cultured explants","volume":"55","author":"Jourdan","year":"2012","journal-title":"Hepatology"},{"key":"key20180107234242_b43-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/15216540051081092","article-title":"4-Hydroxynonenal in the pathomechanisms of oxidative stress","volume":"50","author":"Poli","year":"2000","journal-title":"IUBMB Life"},{"key":"key20180107234242_b44-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"P\u00e9rez-Carreras","year":"2003","journal-title":"Hepatology"},{"key":"key20180107234242_b45-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMc1006581","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"363","author":"Violi","year":"2010","journal-title":"N Engl J Med"},{"key":"key20180107234242_b46-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network: Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"key20180107234242_b47-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/labinvest.2011.55","article-title":"Fatty liver is associated with impaired activity of PPAR\u03b3-coactivator 1\u03b1 (PGC1\u03b1) and mitochondrial biogenesis in mice","volume":"91","author":"Aharoni-Simon","year":"2011","journal-title":"Lab Invest"},{"key":"key20180107234242_b48-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.metabol.2010.12.001","article-title":"Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo","volume":"60","author":"Wang","year":"2011","journal-title":"Metabolism"},{"key":"key20180107234242_b49-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"key20180107234242_b50-ijmm-37-03-0743","first-page":"876","article-title":"In vivo effects of CB1 receptor ligands on lipid peroxidation and antioxidant defense systems in the rat brain of healthy and ethanol-treated rats","volume":"58","author":"Tsvetanova","year":"2006","journal-title":"Pharmacol Rep"},{"key":"key20180107234242_b51-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.biocel.2003.10.002","article-title":"Hepatocytes: critical for glucose homeostasis","volume":"36","author":"Klover","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107234242_b52-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1463-1326.2011.01536.x","article-title":"Obesity and type 2 diabetes: which patients are at risk?","volume":"14","author":"Garber","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"key20180107234242_b53-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/hep.27686","article-title":"Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms","volume":"61","author":"Mukhopadhyay","year":"2015","journal-title":"Hepatology"},{"key":"key20180107234242_b54-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.numecd.2013.01.006","article-title":"Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers","volume":"23","author":"Sesti","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"key20180107234242_b55-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"key20180107234242_b56-ijmm-37-03-0743","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1021\/jm401158e","article-title":"Discovery of 1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido) methyl)-5-(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with significant weight-loss efficacy in diet-induced obese mice","volume":"56","author":"Chang","year":"2013","journal-title":"J Med Chem"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2016.2475\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T19:17:05Z","timestamp":1515352625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2016.2475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,1,29]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/ijmm.2016.2475"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2016.2475","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]}}}